MTFR2 knockdown in aHSCs led to reduced expression of key FAO enzymes, CPT1A and carnitine palmitoyl transferase 2 (CPT2) in HCC cells, while TA9 treatment restored their levels (Figure 2E and Figure S7C,D, Supporting Information). The gene discussed is CPT1A; the disease is hepatocellular carcinoma.